167 related articles for article (PubMed ID: 33312731)
1. The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy.
Quhal F; Abufaraj M; Janisch F; Mori K; Lysenko I; Mostafaei H; D'Andrea D; Mathieu R; Enikeev DV; Fajkovic H; Heidenreich A; Shariat SF
Arab J Urol; 2020 May; 18(4):213-218. PubMed ID: 33312731
[TBL] [Abstract][Full Text] [Related]
2. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
[TBL] [Abstract][Full Text] [Related]
3. The role of lymph node dissection in salvage radical prostatectomy for patients with radiation recurrent prostate cancer.
Quhal F; Rajwa P; Mori K; Laukhtina E; Grossmann NC; Schuettfort VM; König F; Aydh A; Motlagh RS; Katayama S; Mostafai H; Pradere B; Marra G; Gontero P; Mathieu R; Karakiewicz PI; Briganti A; Shariat SF; Heidenreich A
Prostate; 2021 Aug; 81(11):765-771. PubMed ID: 34057227
[TBL] [Abstract][Full Text] [Related]
4. Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
Laukhtina E; Pradere B; D Andrea D; Rosiello G; Luzzago S; Pecoraro A; Palumbo C; Knipper S; Karakiewicz PI; Margulis V; Quhal F; Sari Motlagh R; Mostafaei H; Mori K; Kimura S; Enikeev D; Shariat SF
Urol Oncol; 2020 Dec; 38(12):936.e7-936.e14. PubMed ID: 32962909
[TBL] [Abstract][Full Text] [Related]
5. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative albumin to globulin ratio in patients treated with salvage radical prostatectomy for radiation recurrent prostate cancer.
Quhal F; Pradere B; Sari Motlagh R; Mori K; Laukhtina E; Aydh A; Mostafaei H; Lysenko I; Schuettfort VM; Stolzenbach F; Palumbo C; Heidenreich A; Briganti A; Karakiewicz PI; Chlosta P; Shariat SF
Minerva Urol Nephrol; 2021 Oct; 73(5):610-615. PubMed ID: 32993278
[TBL] [Abstract][Full Text] [Related]
7. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
8. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy.
Preisser F; Incesu RB; Rajwa P; Chlosta M; Ahmed M; Abreu AL; Cacciamani G; Ribeiro L; Kretschmer A; Westhofen T; Smith JA; Graefen M; Calleris G; Raskin Y; Gontero P; Joniau S; Sanchez-Salas R; Shariat SF; Gill I; Karnes RJ; Cathcart P; Van Der Poel H; Marra G; Tilki D
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370733
[TBL] [Abstract][Full Text] [Related]
10. Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy.
Rajwa P; Schuettfort VM; Quhal F; Mori K; Katayama S; Laukhtina E; Pradere B; Motlagh RS; Mostafaei H; Grossmann NC; Aulitzky A; Paradysz A; Karakiewicz PI; Fajkovic H; Zimmermann K; Heidenreich A; Gontero P; Shariat SF
World J Urol; 2021 Oct; 39(10):3771-3779. PubMed ID: 33997919
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A
Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium.
Marra G; Calleris G; Conte F; Benfant N; Rajwa P; Ahmed M; Abreu A; Cacciamani G; Smith JA; Joniau S; Rodriguez-Sanchez L; Sanchez-Salas R; Cathcart P; Gill I; Karnes RJ; Tilki D; Shariat SF; Touijer K; Gontero P
Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37704503
[TBL] [Abstract][Full Text] [Related]
13. Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer.
Mari A; Abufaraj M; Foerster B; Özsoy M; Briganti A; Rouprêt M; Karakiewicz PI; Mathieu R; D'Andrea D; Chade DC; Shariat SF
Clin Genitourin Cancer; 2018 Jun; 16(3):e619-e627. PubMed ID: 29239845
[TBL] [Abstract][Full Text] [Related]
14. Role of serum cholinesterase in patients treated with salvage radical prostatectomy.
Vartolomei MD; D'Andrea D; Chade DC; Soria F; Kimura S; Foerster B; Abufaraj M; Mathieu R; Moschini M; Rouprêt M; Briganti A; Karakiewicz PI; Shariat SF
Urol Oncol; 2019 Feb; 37(2):123-129. PubMed ID: 30522902
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
[TBL] [Abstract][Full Text] [Related]
16. Survival Outcomes in Men Undergoing Radical Prostatectomy After Primary Radiation Treatment for Adenocarcinoma of the Prostate.
Pokala N; Huynh DL; Henderson AA; Johans C
Clin Genitourin Cancer; 2016 Jun; 14(3):218-25. PubMed ID: 26774347
[TBL] [Abstract][Full Text] [Related]
17. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis.
Aydh A; Motlagh RS; Abufaraj M; Mori K; Katayama S; Grossmann N; Rajwa P; Mostafai H; Laukhtina E; Pradere B; Quhal F; Schuettfort VM; Briganti A; Karakiewicz PI; Fajkovic H; Shariat SF
Arab J Urol; 2022; 20(2):71-80. PubMed ID: 35530569
[TBL] [Abstract][Full Text] [Related]
19. Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.
Poelaert F; Fonteyne V; Ost P; De Troyer B; Decaestecker K; De Meerleer G; De Visschere P; Claeys T; Dhondt B; Lumen N
Strahlenther Onkol; 2017 Jun; 193(6):444-451. PubMed ID: 28101585
[TBL] [Abstract][Full Text] [Related]
20. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
